About Halix b.v.
Halix b.v. is a leading Contract Development and Manufacturing Organization (CDMO) that specializes in the development and GMP manufacturing of viral vectors and recombinant proteins on clinical and commercial scales. The company has been providing end-to-end services to its clients for many years, helping them to bring their products to market quickly and efficiently.
At Halix b.v., the team of experts is dedicated to delivering high-quality services that meet the needs of their clients. They work closely with their customers throughout the entire process, from initial concept development through final product delivery. This approach ensures that all aspects of the project are carefully considered, resulting in a successful outcome.
One of the key strengths of Halix b.v. is its state-of-the-art facilities, which are equipped with cutting-edge technology for both upstream and downstream processing. The company's manufacturing capabilities include bioreactors up to 2000L scale, purification suites with multiple chromatography systems, as well as fill & finish capabilities for vials or syringes.
Halix b.v.'s expertise extends beyond just manufacturing; they also offer comprehensive analytical services including method development & validation, stability studies, release testing & characterization studies. Their analytical team works closely with clients to ensure that all necessary testing is performed accurately and efficiently.
The company's commitment to quality is evident in its adherence to strict regulatory guidelines such as cGMP (current Good Manufacturing Practices), ICH (International Council for Harmonisation) guidelines as well as ISO 9001:2015 certification which ensures consistent quality management practices across all operations.
Halix b.v.'s focus on innovation has led them to develop proprietary technologies such as ViroCap™ - a next-generation sequencing-based assay designed specifically for virus detection in biopharmaceutical products - which enables rapid identification of potential contaminants during production processes.
In addition to its core competencies in viral vector production & recombinant protein expression systems, Halix b.v. also offers a range of other services including cell line development, process development & optimization, and formulation development.
The company's commitment to sustainability is evident in its efforts to reduce waste and energy consumption through the use of renewable energy sources such as solar panels. Halix b.v. also actively participates in community outreach programs aimed at promoting science education and supporting local charities.
In conclusion, Halix b.v. is a leading CDMO that provides end-to-end services for the development and GMP manufacturing of viral vectors and recombinant proteins on clinical & commercial scales. With state-of-the-art facilities, cutting-edge technology, proprietary technologies like ViroCap™ assay, comprehensive analytical services & expertise in regulatory guidelines like cGMP & ICH guidelines as well as ISO 9001:2015 certification ensures consistent quality management practices across all operations makes them stand out from their competitors. Their focus on innovation, sustainability efforts along with community outreach programs make them an ideal partner for companies looking to bring their products to market quickly and efficiently while maintaining high-quality standards throughout the entire process.